Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Shruti D Dave"'
Autor:
Vivek B Kute, Sandeep Guleria, Anil K Bhalla, Ashish Sharma, Sanjay K Agarwal, Manisha Sahay, Santosh Varughese, Narayan Prasad, Prem P Varma, Sunil Shroff, Harsh Vardhan, Manish R Balwani, Shruti D Dave, Dhamendra Bhadauria, Manish Rathi, Dhananjai Agrawal, Pankaj R Shah, Jai Prakash
Publikováno v:
Indian Journal of Transplantation, Vol 15, Iss 2, Pp 131-133 (2021)
Externí odkaz:
https://doaj.org/article/763fc7ed5fda4583a40b9ffebc055038
Autor:
Aruna V Vanikar, Hargovind L Trivedi, Pankaj R Shah, Kamal V Kanodia, Rashmi D Patel, Pranjal R Modi, Shruti D Dave, Atin M Singhai, Veena R Shah, Varsha B Trivedi, V Shankar
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 24, Iss 1, Pp 15-21 (2013)
Recurrence of primary focal segmental glomerulosclerosis (FSGS) is an important cause of graft loss after renal transplantation (RTx). We report our experience in 34 patients with primary FSGS who underwent RTx between April 1999 and June 2009, using
Externí odkaz:
https://doaj.org/article/9ac386dd36c74bb8986da771a1c13aeb
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 16, Iss 7, Pp 65-69 (2012)
Background: Diabetics are incapable of producing insulin/have autoimmune mechanisms making it ineffective to control glucose secretion. We present a prospective study of glucose-sensitive insulin-secreting mesenchymal stem cells (IS-MSC) generated fr
Externí odkaz:
https://doaj.org/article/e771d4da460446b2b79352ee9b4d3c48
Autor:
Umang G Thakkar, Aruna V Vanikar, Hargovind L Trivedi, Veena R Shah, Shruti D Dave, Satyajit B Dixit, Bharat B Tiwari, Harda H Shah
Publikováno v:
Advanced Biomedical Research, Vol 5, Iss 1, Pp 51-51 (2016)
Background: Spinal cord injury (SCI) is not likely to recover by current therapeutic modalities. Stem cell (SC) therapy (SCT) has promising results in regenerative medicine. We present our experience of co-infusion of autologous adipose tissue derive
Externí odkaz:
https://doaj.org/article/a3587f444858408b9b6cf3a76f1b0ce3
Autor:
Manish Rathi, Dhananjai Agrawal, Sunil Shroff, Jai Prakash, Vivek B Kute, Manisha Sahay, Harsh Vardhan, Santosh Varughese, Manish R Balwani, Sanjay K. Agarwal, Anil Kumar Bhalla, Dhamendra Bhadauria, Ashish Sharma, Shruti D Dave, Sandeep Guleria, Narayan Prasad, Pankaj R Shah, Prem P. Varma
Publikováno v:
Indian Journal of Transplantation, Vol 15, Iss 2, Pp 131-133 (2021)
The National Organ and Tissue Transplant Organization (NOTTO) has previously published transplant-specific guidelines with reference to COVID-19.([1]) The mortality is higher in dialysis patients with COVID-19 (12%-30%) than posttransplant COVID-19 p
Publikováno v:
Current Stem Cell Research & Therapy. 12:288-299
A synergy of a pre-accumulated genes with an autoimmunity advancing to slow abolition of pancreatic beta-cells causes insulin deficiency and results enrooting insulin dependent diabetes mellitus (IDDM). As per WHO data worldwide about 150 million peo
Publikováno v:
Current Biotechnology. 6:26-32
Publikováno v:
International Journal of Diabetes in Developing Countries. 36:426-432
Stem cell therapy (SCT) has promising results in regeneration of injured tissues/cells as well as correcting immune dysregulation. We present our experience of co-infusion of human adipose tissue-derived insulin-secreting mesenchymal stem cells (IS-A
Publikováno v:
Renal Failure. 36:457-460
Transplantation tolerance is still a Utopian dream for many transplanters. Mesenchymal stem cells (MSC) have shown immuno-modulatory and tolerogenic effects in experimental models. We present a 29-year-old male with end stage renal disease (ESRD) who
Autor:
Shruti D Dave
Publikováno v:
Current Stem Cell Research & Therapy. 8:471-483
Diabetes mellitus (DM) is considered to be an autoimmune disorder leading to destruction of beta-cells resulting in to a loss of blood sugar control. Attempts using many pharmacological compositions including exogenous insulin have failed to show tig